In vivo effects of arsenic trioxide in refractory acute myeloid leukemia other than acute promyelocytic leukemia.

被引：0
|
作者：
Geissler, K
Berer, A
Gisslinger, H
Keil, F
Valent, P
Osterode, W
Lechner, K
机构：
[1] Univ Vienna, Div Hematol & Hemostaseol 1st Med Dept, Vienna, Austria
[2] Univ Vienna, Dept Occupat Med, Vienna, Austria
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4230
引用
收藏
页码：229B / 229B
页数：1
相关论文
共 50 条
  • [1] Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.
    Hunt, Daniel P.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19): : 1866 - 1866
  • [2] Pharmacokinetics of arsenic trioxide in patients with acute promyelocytic leukemia.
    Nagy, AJ
    Wang, ZG
    Maslak, P
    Chanel, S
    Ho, R
    Spriggs, D
    Tong, W
    Ellison, R
    Pandolfi, PP
    Warrell, RP
    Soignet, SL
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 100A - 100A
  • [3] Synergistic effect of gefitinib and arsenic trioxide in acute promyelocytic leukemia.
    Almeida, Luciana Yamamoto
    Araujo Silva, Cleide Lucia
    Weinhauser, Isabel
    Candido, Larissa Ananias
    Scheucher, Priscila Santos
    Oliveira Menezes Bonaldo, Camila Cristina
    Aparecida Santana, Barbara Amelia
    Gouvea Lima Yamada, Ana Silvia
    Rego, Eduardo Magalhaes
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (01) : 81 - 82
  • [4] Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia.
    Mathews, V
    Chandy, M
    Srivastava, A
    Poonkuzhali, B
    Shaji, RV
    George, B
    [J]. BLOOD, 2001, 98 (11) : 216B - 216B
  • [5] Clinical observation on arsenic trioxide in the treatment of acute promyelocytic leukemia.
    Ma, J
    Liu, JW
    Jin, MH
    Xia, GQ
    [J]. EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 484 - 484
  • [6] Arsenic trioxide in the treatment of relapsed and refractory acute promyelocytic leukemia
    Asou, N
    [J]. INTERNAL MEDICINE, 2005, 44 (08) : 775 - 776
  • [7] A phase I/II trial of arsenic trioxide for relapsed and refractory-acute promyelocytic leukemia.
    Westervelt, P
    Adkins, D
    Brown, R
    Goodnough, LT
    Khoury, H
    Rush, C
    Lojka, T
    Miller, G
    DiPersio, JF
    [J]. BLOOD, 1998, 92 (10) : 219B - 219B
  • [8] Clinical observation on arsenic trioxide in the treatment of relapsed acute promyelocytic leukemia.
    Ma, J
    Jin, MH
    Chen, LY
    Liang, H
    Zhang, Y
    [J]. BLOOD, 1998, 92 (10) : 404A - 404A
  • [9] Arsenic trioxide in the treatment of acute promyelocytic leukemia. A review of current evidence
    Sanz, Miguel A.
    Fenaux, Pierre
    Lo Coco, Francesco
    Amadori, Sergio
    Buchner, T.
    Burnett, Alan K.
    Cimino, Giuseppe
    Doehner, H.
    Dombret, Herve
    Lengfelder, E.
    Lowenberg, Bob
    Ludwig, H.
    Sanz, Miguel
    [J]. HAEMATOLOGICA, 2005, 90 (09) : 1231 - 1235
  • [10] Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias
    Yousefnia, Saghar
    [J]. CELL BIOLOGY INTERNATIONAL, 2021, 45 (06) : 1148 - 1157
12345